Oral semaglutide cuts major heart risks in people with type 2 diabetes by 14%, offering a powerful pill-based option. Both ...

Novo Nordisk’s SOUL trial confirms that oral semaglutide significantly reduces the risk of heart attack, stroke, and ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial, ...

💊 A new international clinical trial found that oral semaglutide ... population prone to heart attacks, strokes, and related complications, showing similar benefits to its injectable counterpart.

Findings from the American College of Cardiology 2025 Annual Scientific Session show oral semaglutide ... benefits they’re looking for. Some patients with a personal or family history of heart ...

McGuire, MD, MHSc, professor of medicine in the division of cardiology, Dallas Heart Ball Chair ... support the fact that oral semaglutide will generate the same CV benefits as the rest of the ...

“The same cardiovascular benefits can be derived from ... The 26% reduction in the rate of non-fatal heart attack among patients taking oral semaglutide was the primary driver of the improvement ...

Recent study shows oral semaglutide reduces cardiovascular risk in type 2 diabetes patients, enhancing diabetes and heart ...

Oral semaglutide reduced major cardiovascular events by 14% in patients with type 2 diabetes over nearly 4 years. The trial involved 9650 patients with type 2 diabetes and cardiovascular or kidney ...

Benefits of Semaglutide Well Known The US Food and Drug Administration requires that all new medications for type 2 diabetes clear a cardiovascular safety hurdle before approval, and oral semaglutide ...